PubMed Health⌕ Search

PubMed · 17070012

Experimental investigation on breast tissue classification based on statistical feature extraction of mammograms.

Abstract

An important approach for describing a region is to quantify its structure content. In this paper, the use of functions for computing texture based on statistical measures is described. Six textural features for mammogram images are defined. The segmentation based on these textures would classify the breast tissue under four categories. The algorithm evaluates the region properties of the mammogram image and thereby would classify the image under four important categories based on the intensity level of histograms. Experiments have been conducted on images of mini-MIAS database (Mammogram Image Analysis Society database (UK)). The breast tissue classification thus obtained is comparatively better than the other normal methods. The validation of the work has been done by visual inspection of the segmented image by an expert radiologist. This work is a part of developing a computer aided decision (CAD) system for early detection of breast cancer. The classification results agree with the standard specified by the ACR-BIRADS (American College of Radiology-Breat Imaging And Reporting Data Systems). The accuracy of classification has been found to be 80% as per the visual inspection by an expert radiologist.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

H S Sheshadri, A Kandaswamy. 2006-10-27. Experimental investigation on breast tissue classification based on statistical feature extraction of mammograms.. https://doi.org/10.1016/j.compmedimag.2006.09.015

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

FOXA1: Growth inhibitor and a favorable prognostic factor in human breast cancer.

The transcription factor Forkhead-box A1 (Foxa1), a member of the FOX class of transcription factors, has been implicated in the pathogenesis of lung, esophageal and prostate cancers. We have recently identified transcriptional activation of p27 by FOXA1. In this study, we analyzed the activities and expression pattern of FOXA1 in breast cancer. Forced expression of FOXA1 inhibited clonal growth of breast cancer cell lines, and FOXA1 levels inversely correlated with growth stimuli. In the estrogen receptor (ER)-positive MCF-7 cells, FOXA1 increased p27 promoter activity and inhibited the ER pathway activity. Analysis of FOXA1 expression in breast tissue arrays revealed significantly higher expression in pure ductal carcinomas in situ compared to invasive ductal carcinomas (IDC); and in IDC, high expression of FOXA1 was associated with favorable prognostic factors. Yet, FOXA1 expression was noted in a subset of the ER-negative tumors. Taken together, our findings suggest a growth inhibitory role for FOXA1, and identify it as a novel, potential prognostic factor in breast cancer.

Breast↗

The prognostic role of a gene signature from tumorigenic breast-cancer cells.

BACKGROUND: Breast cancers contain a minority population of cancer cells characterized by CD44 expression but low or undetectable levels of CD24 (CD44+CD24-/low) that have higher tumorigenic capacity than other subtypes of cancer cells. METHODS: We compared the gene-expression profile of CD44+CD24-/low tumorigenic breast-cancer cells with that of normal breast epithelium. Differentially expressed genes were used to generate a 186-gene "invasiveness" gene signature (IGS), which was evaluated for its association with overall survival and metastasis-free survival in patients with breast cancer or other types of cancer. RESULTS: There was a significant association between the IGS and both overall and metastasis-free survival (P<0.001, for both) in patients with breast cancer, which was independent of established clinical and pathological variables. When combined with the prognostic criteria of the National Institutes of Health, the IGS was used to stratify patients with high-risk early breast cancer into prognostic categories (good or poor); among patients with a good prognosis, the 10-year rate of metastasis-free survival was 81%, and among those with a poor prognosis, it was 57%. The IGS was also associated with the prognosis in medulloblastoma (P=0.004), lung cancer (P=0.03), and prostate cancer (P=0.01). The prognostic power of the IGS was increased when combined with the wound-response (WR) signature. CONCLUSIONS: The IGS is strongly associated with metastasis-free survival and overall survival for four different types of tumors. This genetic signature of tumorigenic breast-cancer cells was even more strongly associated with clinical outcomes when combined with the WR signature in breast cancer.

Breast↗